NCT06102395 2023-10-30
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Beijing Tongren Hospital
Phase 3 Recruiting
Beijing Tongren Hospital
Affiliated Cancer Hospital & Institute of Guangzhou Medical University